Literature DB >> 14568247

Hemopoietic progenitor cells and bone marrow stromal cells in patients with autoimmune hepatitis type 1 and primary biliary cirrhosis.

Despina S Kyriakou1, Michael G Alexandrakis, Kalliopi Zachou, Freda Passam, Nikolaos E Stathakis, Georgios N Dalekos.   

Abstract

BACKGROUND/AIMS: Autologous hematopoietic stem cell transplantation has been used in severe cases of autoimmunity. We investigated whether hemopoietic progenitor cells and/or bone marrow (BM) microenvironment are affected in autoimmune hepatitis type-1 (AIH-1) and primary biliary cirrhosis (PBC).
METHODS: We studied 13 AIH-1 patients, 13 PBC patients, 12 cirrhotic controls (CC) and ten healthy controls (HC). Flow cytometry, expansion cultures, long-term BM cultures and clonogenic progenitor cell assays were used. Stromal cell function was assessed in long-term BM cultures recharged with normal CD34+ cells.
RESULTS: AIH-1 had increased CD34+, CD34+/CD38+ and CD34+/CD38- cells compared to all groups (P<0.001). PBC had lower progenitor cells compared to controls (P<0.005). No differences were found between CC and HC. Committed progenitor cells in non-adherent cell fraction were increased in AIH-1 (P<0.05) but decreased in PBC compared to controls (P<0.05). Granulocyte-macrophage colony forming units (CFU) and erythroid-burst CFU were increased in AIH-1 compared to all groups (P<0.001). PBC had these CFUs decreased compared to controls (P<0.005). Stromal cells failed to support normal hemopoiesis in PBC.
CONCLUSIONS: We demonstrated for the first time that AIH-1 had increased hemopoietic progenitor cells and normal stromal function. In PBC, progenitor cells and BM microenvironment were defective. Further studies will determine the significance of these novel findings.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14568247     DOI: 10.1016/s0168-8278(03)00387-8

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  11 in total

1.  Primary biliary cirrhosis-specific autoantibodies in first degree relatives of Greek primary biliary cirrhosis patients.

Authors:  Theodoros A Zografos; Nikolaos Gatselis; Kalliopi Zachou; Christos Liaskos; Stella Gabeta; George K Koukoulis; George N Dalekos
Journal:  World J Gastroenterol       Date:  2012-09-14       Impact factor: 5.742

2.  IgA anti-b2GPI antibodies in patients with autoimmune liver diseases.

Authors:  Stella Gabeta; Gary L Norman; Nikolaos Gatselis; Christos Liaskos; Panagiotis A Papamichalis; Athanasios Garagounis; Kalliopi Zachou; Eirini I Rigopoulou; George N Dalekos
Journal:  J Clin Immunol       Date:  2008-06-13       Impact factor: 8.317

3.  Double reactivity against actin and alpha-actinin defines a severe form of autoimmune hepatitis type 1.

Authors:  Paul Guéguen; Georgios Dalekos; Jean-Baptiste Nousbaum; Kalliopi Zachou; Chaim Putterman; Pierre Youinou; Yves Renaudineau
Journal:  J Clin Immunol       Date:  2006-09-26       Impact factor: 8.542

4.  Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease.

Authors:  Kalliopi Zachou; Eirini Rigopoulou; George N Dalekos
Journal:  J Autoimmune Dis       Date:  2004-10-15

5.  Erythrocyte count is associated with prognosis in Chinese patients with primary biliary cholangitis.

Authors:  Yinghao Chang; Changcun Guo; Guanya Guo; Zhou Yuan; Xinmin Zhou; Jingbo Wang; Zheyi Han; Yu Chen; Gui Jia; Ying Han
Journal:  Exp Ther Med       Date:  2020-01-13       Impact factor: 2.447

6.  Distinct microRNAs expression profile in primary biliary cirrhosis and evaluation of miR 505-3p and miR197-3p as novel biomarkers.

Authors:  Masashi Ninomiya; Yasuteru Kondo; Ryo Funayama; Takeshi Nagashima; Takayuki Kogure; Eiji Kakazu; Osamu Kimura; Yoshiyuki Ueno; Keiko Nakayama; Tooru Shimosegawa
Journal:  PLoS One       Date:  2013-06-12       Impact factor: 3.240

7.  Diagnostic relevance and clinical significance of the new enhanced performance M2 (MIT3) ELISA for the detection of IgA and IgG antimitochondrial antibodies in primary biliary cirrhosis.

Authors:  Stella Gabeta; Gary L Norman; Christos Liaskos; Panagiotis A Papamichalis; Theodoros Zografos; Athanasios Garagounis; Eirini I Rigopoulou; George N Dalekos
Journal:  J Clin Immunol       Date:  2007-05-21       Impact factor: 8.542

8.  The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders.

Authors:  Panagiotis A Papamichalis; Kalliopi Zachou; George K Koukoulis; Aikaterini Veloni; Efthimia G Karacosta; Lampros Kypri; Ioannis Mamaloudis; Stella Gabeta; Eirini I Rigopoulou; Ansgar W Lohse; George N Dalekos
Journal:  J Autoimmune Dis       Date:  2007-06-29

9.  Mesenchymal stem cell transplantation improves chronic colitis-associated complications through inhibiting the activity of toll-like receptor-4 in mice.

Authors:  Guo Chao Niu; Lei Liu; Libo Zheng; Hong Zhang; David Q Shih; Xiaolan Zhang
Journal:  BMC Gastroenterol       Date:  2018-08-13       Impact factor: 3.067

10.  IFN-γ-STAT1-iNOS Induces Myeloid Progenitors to Acquire Immunosuppressive Activity.

Authors:  Shu-Han Yang; Liang Li; Yu-Qing Xie; Yuan Yao; Cai-Yue Gao; Liang-Huan Liao; Hong-Di Ma; M Eric Gershwin; Zhe-Xiong Lian
Journal:  Front Immunol       Date:  2017-09-22       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.